# Setting Up a PBPK Model in OSP using AI/Agentic Workflows

## Executive Summary

This document provides a comprehensive guide for PBPK modeling experts to set up physiologically-based pharmacokinetic (PBPK) models in the Open Systems Pharmacology (OSP) Suite using AI-powered and agentic workflows. It outlines the complete workflow from initial data gathering through model refinement, incorporating both traditional OSP tools (PK-Sim, MoBi, R packages) and emerging AI technologies to enhance efficiency, reproducibility, and quality.

## Table of Contents

1. [Overview](#overview)
2. [Required Inputs](#required-inputs)
3. [Workflow Architecture](#workflow-architecture)
4. [OSP Tools Integration](#osp-tools-integration)
5. [AI Tools and Agentic Systems](#ai-tools-and-agentic-systems)
6. [Iterative Model Refinement Process](#iterative-model-refinement-process)
7. [Quality Assurance and Validation](#quality-assurance-and-validation)
8. [Documentation and Reporting](#documentation-and-reporting)
9. [Implementation Roadmap](#implementation-roadmap)

---

## Overview

### What are AI/Agentic Workflows?

**Agentic AI systems** are autonomous agents capable of:
- Making decisions based on defined objectives and constraints
- Orchestrating complex multi-step workflows
- Managing data pipelines and validation checkpoints
- Learning from previous iterations to improve recommendations
- Enforcing best practices and regulatory compliance standards

In the context of PBPK modeling, agentic workflows can automate repetitive tasks, ensure consistency, provide decision support, and maintain comprehensive documentation trails—all critical for modern drug development and regulatory submissions.

### Benefits for PBPK Modeling

- **Efficiency**: Automate routine tasks (parameter searches, literature reviews, report generation)
- **Reproducibility**: Ensure consistent methodology across projects
- **Quality**: Reduce human error through automated validation
- **Traceability**: Maintain complete audit trails for regulatory compliance
- **Scalability**: Handle multiple compounds and scenarios simultaneously
- **Innovation**: Free experts to focus on scientific decisions rather than technical implementation

---

## Required Inputs

### 1. Compound Information

#### Physicochemical Properties
- **Molecular weight** (Da)
- **LogP** (lipophilicity)
- **Compound type** (small molecule, large molecule, biologic)
- **pKa values** (acid/base dissociation constants)
- **Solubility** (aqueous, pH-dependent)
- **Protein binding** (fu, fraction unbound in plasma)
- **Blood-to-plasma ratio**

**AI Support**:
- Automated extraction from chemical structure (SMILES, InChI)
- Literature mining for missing parameters
- Prediction using QSAR/machine learning models
- Validation against compound databases (ChEMBL, DrugBank, PubChem)

#### ADME Properties
- **Absorption**: Intestinal permeability, dissolution parameters
- **Distribution**: Tissue partition coefficients, Vss
- **Metabolism**: Enzyme kinetics (Km, Vmax, CLint), metabolic pathways
- **Excretion**: Renal clearance, biliary clearance, GFR fraction

**AI Support**:
- Text mining from scientific literature and FDA labels
- Automated extraction from in vitro study reports
- Parameter estimation using machine learning models
- Cross-validation with similar compounds

### 2. Clinical Data

#### Pharmacokinetic Data
- **Single dose PK**: Concentration-time profiles (plasma, blood, tissues)
- **Multiple dose PK**: Steady-state profiles, accumulation
- **Dose-proportionality**: Linear/non-linear kinetics assessment
- **Food effects**: Fed vs. fasted states
- **Formulation effects**: Different dosage forms

#### Study Metadata
- **Demographics**: Age, weight, height, gender, ethnicity
- **Health status**: Healthy volunteers vs. patient populations
- **Dosing regimen**: Dose, route, frequency, duration
- **Study design**: Crossover, parallel, bioequivalence
- **Bioanalytical methods**: Assay type, LLOQ, sample matrix

**AI Support**:
- Automated digitization of published concentration-time curves
- Extraction of metadata from clinical study reports
- Data quality assessment and outlier detection
- Format standardization (conversion to OSP-compatible formats)

### 3. Physiological Information

#### Population Characteristics
- **Species**: Human, rat, dog, monkey, etc.
- **Age range**: Pediatric, adult, geriatric
- **Body composition**: Height, weight, BMI distributions
- **Organ volumes and blood flows**: Species-specific anatomical data
- **Enzyme expression**: CYP, UGT, transporter levels

**AI Support**:
- Automatic selection of appropriate population database from PK-Sim
- Generation of virtual populations matching study demographics
- Prediction of ontogeny factors for pediatric populations

### 4. Drug-Drug Interaction (DDI) Data (if applicable)

- **Perpetrator compounds**: Inhibitors, inducers
- **Victim compounds**: Affected by DDI
- **Interaction mechanisms**: Competitive inhibition, mechanism-based inhibition, induction
- **Clinical DDI studies**: Observed AUC/Cmax ratios

**AI Support**:
- Literature mining for DDI information
- Prediction of DDI potential using structural alerts
- Automated setup of DDI scenarios

### 5. Disease/Special Population Data (if applicable)

- **Hepatic impairment**: Child-Pugh scores, liver function parameters
- **Renal impairment**: Creatinine clearance, eGFR
- **Pregnancy**: Physiological changes during gestation
- **Pediatrics**: Age-dependent maturation factors

### 6. Project Context

#### Strategic Objectives
- **Primary goal**: What question needs to be answered?
  - First-in-human dose prediction
  - Formulation bridging
  - DDI risk assessment
  - Special population dosing
  - Regulatory submission support

#### Constraints and Requirements
- **Timeline**: Project deadlines
- **Regulatory requirements**: FDA, EMA, PMDA guidelines
- **Confidence level**: Exploratory vs. confirmatory modeling
- **Resources**: Available computational resources, team expertise

**AI Support**:
- Template selection based on modeling objective
- Identification of relevant regulatory guidelines
- Recommendation of modeling strategy and complexity level

---

## Workflow Architecture

### High-Level Workflow Stages

```
┌─────────────────────────────────────────────────────────────┐
│                   STAGE 1: INITIALIZATION                   │
│  • Data collection (AI-assisted literature mining)          │
│  • Data preprocessing (AI-assisted standardization)         │
│  • Project setup (template selection)                       │
└───────────────────┬─────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────────────────┐
│              STAGE 2: MODEL CONSTRUCTION                    │
│  • PK-Sim: Initial model setup                              │
│  • Parameter assignment (AI-assisted prediction)            │
│  • MoBi: Advanced customization (if needed)                 │
└───────────────────┬─────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────────────────┐
│              STAGE 3: MODEL SIMULATION                      │
│  • R (ospsuite): Batch simulation execution                 │
│  • Population simulations                                   │
│  • Sensitivity analysis                                     │
└───────────────────┬─────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────────────────┐
│         STAGE 4: EVALUATION & REFINEMENT                    │
│  • Compare simulated vs. observed data                      │
│  • AI agent: Identify discrepancies                         │
│  • Parameter optimization (AI-guided)                       │
│  • Iterate until acceptance criteria met                    │
└───────────────────┬─────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────────────────┐
│         STAGE 5: VALIDATION & QUALIFICATION                 │
│  • External validation datasets                             │
│  • Qualification framework                                  │
│  • Sensitivity and uncertainty analysis                     │
└───────────────────┬─────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────────────────┐
│         STAGE 6: APPLICATION & REPORTING                    │
│  • Scenario simulations (DDI, special populations)          │
│  • AI-assisted report generation                            │
│  • Model repository creation                                │
└─────────────────────────────────────────────────────────────┘
```

### Workflow Control and Orchestration

#### Human-in-the-Loop (HITL) Checkpoints

AI agents should operate with human oversight at critical decision points:

1. **Data acceptance**: Expert reviews AI-curated input data
2. **Model structure**: Expert approves or modifies AI-suggested model architecture
3. **Parameter boundaries**: Expert defines acceptable parameter ranges
4. **Refinement decisions**: Expert decides when model performance is acceptable
5. **Final approval**: Expert reviews all outputs before use in decision-making

#### Automated vs. Manual Tasks

**Automated (AI-driven)**:
- Literature searches and data extraction
- Data format conversion and standardization
- Batch simulation execution
- Goodness-of-fit calculation
- Report generation (initial draft)
- Version control and archiving

**Manual (Expert-driven)**:
- Scientific interpretation of results
- Selection of model structure for complex cases
- Assessment of mechanistic plausibility
- Decision on model acceptance
- Final report review and sign-off

---

## OSP Tools Integration

### 1. PK-Sim: Whole-Body PBPK Model Construction

**Documentation**: https://docs.open-systems-pharmacology.org/working-with-pk-sim/pk-sim-documentation

#### Primary Use Cases

**Initial Model Setup**:
- Create Individual or Population building blocks
- Define Compound properties (physicochemical, ADME)
- Set up Administration Protocols (dose, route, schedule)
- Configure Expression Profiles (enzyme/transporter levels)
- Import Observed Data for comparison

**Building Blocks Created**:
1. **Individual**: Species, age, gender, weight, height
2. **Population**: Virtual populations with demographic variability
3. **Compound**: Drug properties and ADME parameters
4. **Formulation**: Dissolution profiles, particle size distributions
5. **Protocol**: Dosing schedule and administration details
6. **Events**: Meals, circadian rhythms, disease onset
7. **Observers**: Custom outputs (AUC, Cmax, tissue concentrations)

#### AI Integration Points

**Automated Building Block Generation**:
```python
# Pseudocode for AI-assisted PK-Sim setup
ai_agent.create_individual(
    species="human",
    age_range=(25, 45),
    population_type="European ICRP"
)

ai_agent.create_compound(
    name="CompoundX",
    mw=350.5,
    logp=2.8,
    # AI fills missing parameters from predictions
    auto_fill_missing=True,
    validation_level="standard"
)
```

**Parameter Prediction**:
- AI models predict missing ADME parameters
- Cross-validation against internal databases
- Uncertainty quantification for predictions

#### CLI Interface for Automation

**Documentation**: https://docs.open-systems-pharmacology.org/working-with-pk-sim/pk-sim-documentation/pk-sim-command-line-interface

```bash
# Batch execution of PK-Sim projects
PK-Sim.CLI.exe \
  --project="CompoundX_Model.pksim5" \
  --export-to-csv \
  --output-folder="./results"
```

**AI Orchestration**:
- Automated batch processing of multiple scenarios
- Parallel execution of sensitivity analysis
- Export results for downstream R analysis

#### Snapshot Export for Version Control

**Documentation**: https://docs.open-systems-pharmacology.org/working-with-pk-sim/pk-sim-documentation/importing-exporting-project-data-models#exporting-project-to-snapshot-loading-project-from-snapshot

```json
{
  "Version": "12.2",
  "Individuals": [...],
  "Compounds": [...],
  "Simulations": [...]
}
```

**Benefits**:
- Human-readable JSON format
- Git-friendly (track model changes over time)
- AI can parse and validate snapshots
- Easy comparison between model versions

### 2. MoBi: Advanced Model Customization

**Documentation**: https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation

#### When to Use MoBi

- **Complex mechanisms**: Non-standard ADME processes
- **Target-mediated drug disposition (TMDD)**
- **Multi-scale models**: Combining PK and PD
- **Custom organs/compartments**: Tumors, abscesses
- **Disease progression models**: Time-varying parameters
- **Combination therapy**: Multiple drugs with interactions

#### Modularization Concept (v12+)

**Documentation**: https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation/modularization-concept

**Benefits for AI Workflows**:
- **Reusable components**: AI can maintain library of validated modules
- **Mix-and-match**: AI suggests relevant modules for new projects
- **Version control**: Track module evolution separately
- **Collaboration**: Teams share standardized modules

**Example Workflow**:
```
Base PBPK Model (from PK-Sim)
  ├─ Import to MoBi
  ├─ Add Module: Tumor Growth
  ├─ Add Module: Antibody Binding
  └─ Add Module: Immune Response
```

**AI Support**:
- Recommend relevant modules based on project objectives
- Validate module compatibility
- Automate module integration testing

#### SBML Import

MoBi can import models in SBML format, enabling:
- Integration with systems biology models
- Reuse of published pathway models
- AI agents can fetch relevant SBML models from BioModels database

### 3. R Package Ecosystem

**Documentation**: https://www.open-systems-pharmacology.org/OSPSuite-R/

#### Core Package: ospsuite

**Repository**: https://github.com/Open-Systems-Pharmacology/OSPSuite-R

**Key Capabilities**:
```r
library(ospsuite)

# Load simulation
sim <- loadSimulation("path/to/model.pkml")

# Modify parameters programmatically
setParameterValues(sim,
  list(
    "Organism|Liver|Volume" = 1.5,
    "Compound|Lipophilicity" = 2.8
  )
)

# Run simulation
results <- runSimulation(sim)

# Extract outputs
plasma_conc <- getOutputValues(results,
  "Organism|PeripheralVenousBlood|CompoundX|Plasma (Peripheral Venous Blood)")
```

**AI Integration**:
- **Automated scripting**: AI generates R code for routine tasks
- **Batch processing**: Run hundreds of scenarios overnight
- **Sensitivity analysis**: Systematic parameter variation
- **Population simulation**: Monte Carlo sampling

#### Parameter Identification: ospsuite.parameteridentification

**Repository**: https://github.com/Open-Systems-Pharmacology/OSPSuite.ParameterIdentification

**Purpose**: Fit model parameters to observed data

```r
library(ospsuite.parameteridentification)

# Define parameters to optimize
params_to_fit <- c(
  "Compound|Permeability",
  "Compound|Specific clearance"
)

# Define observed data
observed_data <- loadObservedData("clinical_data.csv")

# Configure optimization
config <- createOptimizationConfiguration(
  algorithm = "Levenberg-Marquardt",
  tolerance = 1e-3
)

# Run optimization
result <- optimizeParameters(
  simulation = sim,
  parameters = params_to_fit,
  observed_data = observed_data,
  configuration = config
)
```

**AI Enhancement**:
- **Smart initialization**: AI suggests starting parameter values
- **Constraint definition**: AI recommends physiologically-plausible bounds
- **Multi-objective optimization**: Balance fit quality with parameter plausibility
- **Identifiability analysis**: AI flags parameters that cannot be uniquely determined

#### Reporting: ospsuite.reportingengine

**Repository**: https://github.com/Open-Systems-Pharmacology/OSPSuite.ReportingEngine
**Documentation**: https://www.open-systems-pharmacology.org/OSPSuite.ReportingEngine/

**Automated Report Generation**:
```r
library(ospsuite.reportingengine)

# Create report configuration
report_config <- createReportConfiguration(
  title = "CompoundX PBPK Model Evaluation",
  author = "Modeling Team",
  output_format = "docx"  # or "markdown"
)

# Generate report
generateReport(
  configuration = report_config,
  simulation = sim,
  observed_data = observed_data,
  output_path = "./reports/CompoundX_Evaluation.docx"
)
```

**Report Sections (Auto-generated)**:
- Model structure overview
- Parameter values table
- Goodness-of-fit plots
- Prediction vs. observation
- Residual analysis
- Model performance metrics

**AI Enhancement**:
- **Narrative generation**: AI writes interpretation text
- **Figure selection**: AI chooses most informative visualizations
- **Anomaly highlighting**: AI flags unusual results
- **Recommendations**: AI suggests next steps

#### Visualization: tlf (Tables, Listings, Figures)

**Repository**: https://github.com/Open-Systems-Pharmacology/TLF-Library
**Documentation**: https://www.open-systems-pharmacology.org/TLF-Library/

**Standardized Plots**:
```r
library(tlf)

# Create observed vs. predicted plot
plotObsVsPred(
  observed = observed_data,
  predicted = simulated_data,
  fold_distance = 2,  # Show 2-fold error lines
  output_path = "./figures/obs_vs_pred.png"
)

# Create concentration-time plot
plotTimeProfile(
  data = results,
  observed_data = observed_data,
  y_scale = "log",
  output_path = "./figures/time_profile.png"
)
```

**AI Integration**:
- Automated figure generation for reports
- Adaptive scaling and formatting
- Multi-panel layouts for complex comparisons

### 4. Qualification Framework

**Documentation**: https://docs.open-systems-pharmacology.org/shared-tools-and-example-workflows/qualification

**Purpose**: Systematic validation of PBPK models

#### Qualification Plan Structure

```json
{
  "Projects": [
    {
      "Id": "Study_1",
      "Path": "./simulations/study1.pkml",
      "SimulationParameters": [...],
      "OutputMappings": [...]
    }
  ],
  "ObservedDataSets": [...],
  "Plots": [...],
  "Inputs": [...],
  "Sections": [...]
}
```

#### Qualification Runner

**Repository**: https://github.com/Open-Systems-Pharmacology/QualificationRunner

**Execution**:
```bash
# Run qualification plan
qualification-runner \
  --input qualification_plan.json \
  --output ./qualification_report
```

**Outputs**:
- Markdown report with all plots
- Summary statistics (GMFE, AAFE, percentage within 2-fold)
- Pass/fail criteria evaluation

**AI Integration**:
- **Automated plan generation**: AI creates qualification plans from project templates
- **Result interpretation**: AI summarizes model performance
- **Failure diagnosis**: AI suggests reasons for poor fits
- **Acceptance criteria**: AI applies regulatory guidelines to determine model adequacy

### 5. Supporting Tools

#### Installation Validator

**Purpose**: Verify OSP Suite installation integrity

- Validates software functionality
- Runs predefined test scenarios
- Ensures reproducible environment

#### Data Import/Export

**Supported Formats**:
- **Excel**: Clinical data, parameter tables
- **CSV**: Time-series data, population characteristics
- **NONMEM**: Import NONMEM datasets, export for pop-PK analysis
- **JSON**: Snapshots, configuration files
- **PKML**: Native OSP model format

**AI Support**:
- Automated format detection and conversion
- Data quality checks
- Schema validation

---

## AI Tools and Agentic Systems

### AI Tool Categories

#### 1. Natural Language Processing (NLP) Tools

**Use Cases in PBPK Modeling**:

**Literature Mining**:
- Extract compound properties from publications
- Identify relevant clinical studies
- Summarize pharmacology review articles
- Extract DDI information from drug labels

**Recommended Tools**:
- **PubMed AI**: GPT-4-based literature search
- **Elicit**: Research assistant for scientific papers
- **Semantic Scholar API**: Automated paper retrieval
- **BioBERT**: Biomedical text mining
- **SciBERT**: Scientific literature understanding

**Implementation Example**:
```python
# AI agent extracts ADME data from literature
def extract_adme_from_literature(compound_name):
    # Search PubMed
    papers = search_pubmed(f"{compound_name} pharmacokinetics")

    # Extract relevant information
    adme_data = {
        'absorption': extract_absorption_data(papers),
        'distribution': extract_distribution_data(papers),
        'metabolism': extract_metabolism_data(papers),
        'excretion': extract_excretion_data(papers)
    }

    # Cross-validate across papers
    validated_data = cross_validate(adme_data)

    return validated_data
```

#### 2. Machine Learning Prediction Models

**Property Prediction**:

**Physicochemical Properties**:
- LogP, solubility: DeepChem, ChemProp
- pKa: MolGpKa, Marvin
- Permeability: Caco-2 prediction models

**ADME Prediction**:
- Clearance: SVM/RF models trained on internal data
- Vss: Physics-based and ML hybrid models
- Protein binding: QSAR models
- CYP inhibition/induction: Deep learning classifiers

**Recommended Tools/Frameworks**:
- **DeepChem**: Deep learning for drug discovery
- **RDKit**: Cheminformatics toolkit
- **ADMET Predictor**: Commercial tool (Simulation Plus)
- **pkCSM**: ADMET prediction web server
- **ADMETlab**: Comprehensive ADMET prediction

**Integration with OSP**:
```python
# AI predicts missing parameters
predicted_params = ml_model.predict_adme_parameters(
    smiles="CCO",  # Compound structure
    experimental_data={'MW': 46.07, 'LogP': -0.31}
)

# Apply predictions to PK-Sim compound
pksim_compound.set_parameters({
    'Permeability': predicted_params['permeability'],
    'Lipophilicity': predicted_params['logP'],
    'FractionUnbound': predicted_params['fu']
})
```

#### 3. Large Language Models (LLMs)

**Applications**:

**Workflow Orchestration**:
- Interpret user instructions in natural language
- Generate OSP tool commands
- Create R analysis scripts
- Troubleshoot errors

**Code Generation**:
```
User: "Run a sensitivity analysis on clearance and volume parameters"

AI Agent generates:
library(ospsuite)
sim <- loadSimulation("model.pkml")
params <- c("CL", "Vd")
ranges <- list(CL = c(5, 50), Vd = c(100, 500))
sensitivity_results <- run_sensitivity_analysis(sim, params, ranges)
plot_tornado_diagram(sensitivity_results)
```

**Documentation and Explanation**:
- Generate model documentation
- Explain modeling decisions
- Create technical reports
- Provide regulatory context

**Recommended LLMs**:
- **GPT-4 / GPT-4 Turbo**: General-purpose, excellent for coding
- **Claude (Anthropic)**: Strong reasoning, good for scientific contexts
- **Gemini**: Multimodal capabilities
- **Domain-specific fine-tuned models**: Trained on PBPK literature

#### 4. Autonomous Agents and Agentic Frameworks

**Agent Architectures**:

**ReAct (Reasoning + Acting)**:
```
Thought: I need to evaluate model fit
Action: Calculate goodness-of-fit metrics
Observation: GMFE = 1.8, within acceptance criteria
Thought: Model performance is acceptable, proceed to next stage
Action: Generate qualification report
```

**Planning Agents**:
- Break complex tasks into subtasks
- Manage dependencies between tasks
- Allocate resources efficiently

**Tool-Using Agents**:
- Select appropriate OSP tools for each task
- Chain multiple tools together
- Handle errors and retry logic

**Recommended Frameworks**:
- **LangChain**: LLM application framework with agent capabilities
- **AutoGPT**: Autonomous agent for goal-driven tasks
- **BabyAGI**: Task management and prioritization
- **CrewAI**: Multi-agent collaboration
- **Semantic Kernel**: Microsoft's AI orchestration SDK

**Example Agent Workflow**:
```python
class PBPKModelingAgent:
    def __init__(self):
        self.tools = [
            PubMedSearchTool(),
            PKSimTool(),
            MoBiTool(),
            RSimulationTool(),
            ReportGeneratorTool()
        ]

    def setup_model(self, compound_name, objective):
        # Agent reasons about the task
        plan = self.create_plan(compound_name, objective)

        # Execute plan steps
        for step in plan:
            tool = self.select_tool(step)
            result = tool.execute(step)

            # Evaluate result and adapt
            if not self.validate_result(result):
                corrective_action = self.diagnose_issue(result)
                self.execute_correction(corrective_action)

        # Generate deliverables
        return self.create_deliverables()
```

#### 5. Visualization and Dashboard Tools

**Interactive Dashboards**:
- **Shiny (R)**: Interactive web apps for model exploration
- **Plotly Dash (Python)**: Data visualization dashboards
- **Streamlit**: Rapid prototyping of ML apps

**Use Cases**:
- Real-time model refinement interface
- Interactive parameter sensitivity exploration
- Comparison of multiple model versions
- Stakeholder presentations

#### 6. Data Management and Version Control

**Tools**:
- **Git/GitHub**: Version control for models (snapshots, scripts, reports)
- **DVC (Data Version Control)**: Version large datasets
- **MLflow**: Track experiments, parameters, and results
- **Weights & Biases**: Experiment tracking and visualization

**Benefits**:
- Complete audit trail
- Reproducibility
- Collaboration
- Rollback capability

---

## Iterative Model Refinement Process

### Refinement Cycle Overview

```
┌──────────────────────────────────────────────────────────┐
│                  REFINEMENT ITERATION                    │
└──────────────────────────────────────────────────────────┘
         │
         ↓
┌──────────────────────────────────────────────────────────┐
│  Step 1: SIMULATE                                        │
│  • Run current model version                             │
│  • Generate predictions for all scenarios                │
│  • AI Agent: Execute batch simulations via ospsuite      │
└───────────────────┬──────────────────────────────────────┘
                    ↓
┌──────────────────────────────────────────────────────────┐
│  Step 2: EVALUATE                                        │
│  • Compare predictions vs. observations                  │
│  • Calculate goodness-of-fit metrics                     │
│  • AI Agent: Automated GOF calculation and visualization │
│  • Metrics: GMFE, RMSE, AFE, AUC ratio, Cmax ratio      │
└───────────────────┬──────────────────────────────────────┘
                    ↓
┌──────────────────────────────────────────────────────────┐
│  Step 3: DIAGNOSE                                        │
│  • Identify sources of discrepancy                       │
│  • AI Agent: Pattern recognition in residuals            │
│  • Suggest most likely causes (absorption, clearance)    │
│  • Rank parameters by sensitivity                        │
└───────────────────┬──────────────────────────────────────┘
                    ↓
┌──────────────────────────────────────────────────────────┐
│  Step 4: DECIDE                                          │
│  • Human expert reviews AI recommendations               │
│  • Select parameters to adjust                           │
│  • Define acceptable parameter ranges                    │
│  • Approve refinement strategy                           │
└───────────────────┬──────────────────────────────────────┘
                    ↓
┌──────────────────────────────────────────────────────────┐
│  Step 5: REFINE                                          │
│  • Update parameter values                               │
│  • AI Agent: Parameter optimization                      │
│  • Use ospsuite.parameteridentification                  │
│  • Apply physiological constraints                       │
└───────────────────┬──────────────────────────────────────┘
                    ↓
┌──────────────────────────────────────────────────────────┐
│  Step 6: DOCUMENT                                        │
│  • Log changes and rationale                             │
│  • AI Agent: Generate change summary                     │
│  • Commit to version control                             │
│  • Update model documentation                            │
└───────────────────┬──────────────────────────────────────┘
                    ↓
              [Acceptance Check]
                    │
        ┌───────────┴───────────┐
        │                       │
      [Pass]                 [Fail]
        │                       │
        ↓                       ↓
   [COMPLETE]          [Next Iteration] → Go to Step 1
```

### Detailed Refinement Steps

#### Step 1: Simulate

**Automated Simulation Execution**:

```r
# AI-generated simulation script
library(ospsuite)

# Load current model version
sim <- loadSimulation("CompoundX_v1.5.pkml")

# Define simulation scenarios
scenarios <- list(
  study1 = list(dose = 100, route = "IV", population = "adult"),
  study2 = list(dose = 200, route = "PO", population = "adult"),
  study3 = list(dose = 50, route = "PO", population = "pediatric")
)

# Run all scenarios
results <- lapply(scenarios, function(scenario) {
  # Set scenario-specific parameters
  configure_simulation(sim, scenario)

  # Execute
  runSimulation(sim)
})

# Export results
saveSimulationResults(results, "results_v1.5/")
```

**AI Responsibilities**:
- Batch execution management
- Resource allocation (parallel processing)
- Error handling and retry logic
- Progress monitoring

#### Step 2: Evaluate

**Goodness-of-Fit Metrics**:

```r
# Calculate GOF metrics
gof_metrics <- calculate_gof(
  observed = observed_data,
  predicted = simulated_data
)

print(gof_metrics)
# Output:
# GMFE (Geometric Mean Fold Error): 1.45
# AFE (Average Fold Error): 1.23
# AAFE (Absolute Average Fold Error): 1.38
# % within 2-fold: 87%
# RMSE: 25.3 ng/mL
```

**Acceptance Criteria** (example):
- GMFE < 2.0
- ≥80% of data points within 2-fold error
- No systematic bias (visual inspection)

**AI Analysis**:
```python
# AI agent evaluates model performance
def evaluate_model_performance(gof_metrics, acceptance_criteria):
    evaluation = {
        'overall_pass': True,
        'findings': []
    }

    # Check each criterion
    if gof_metrics['GMFE'] > acceptance_criteria['GMFE_threshold']:
        evaluation['overall_pass'] = False
        evaluation['findings'].append(
            f"GMFE ({gof_metrics['GMFE']:.2f}) exceeds threshold"
        )

    # Identify problematic studies
    problematic_studies = identify_outliers(gof_metrics['study_level'])

    if problematic_studies:
        evaluation['findings'].append(
            f"Poor fit in studies: {', '.join(problematic_studies)}"
        )

    return evaluation
```

**Visualization**:
```r
# AI generates diagnostic plots
library(tlf)

# Obs vs Pred
plotObsVsPred(observed_data, predicted_data,
              fold_distance = 2,
              title = "Model v1.5 - Goodness of Fit")

# Residuals over time
plotResidualsVsTime(observed_data, predicted_data)

# Residuals vs predictions
plotResidualsVsPred(observed_data, predicted_data)
```

#### Step 3: Diagnose

**AI-Assisted Root Cause Analysis**:

```python
class ModelDiagnosticAgent:
    def diagnose_misfit(self, observed, predicted, model_structure):
        """
        Identify most likely causes of model-data discrepancy
        """
        issues = []

        # Pattern recognition in residuals
        residuals = calculate_residuals(observed, predicted)

        # Check for systematic bias
        if detect_underprediction_early_timepoints(residuals):
            issues.append({
                'issue': 'Underprediction in absorption phase',
                'likely_cause': 'Intestinal permeability underestimated',
                'suggested_parameters': ['Permeability', 'Dissolution rate'],
                'confidence': 0.85
            })

        if detect_overprediction_late_timepoints(residuals):
            issues.append({
                'issue': 'Overprediction in elimination phase',
                'likely_cause': 'Clearance underestimated',
                'suggested_parameters': ['Hepatic clearance', 'Renal clearance'],
                'confidence': 0.78
            })

        # Check for dose-dependency
        if detect_nonlinear_dose_response(observed, predicted):
            issues.append({
                'issue': 'Non-linear dose-response',
                'likely_cause': 'Saturable metabolism or transporter',
                'suggested_parameters': ['Km', 'Vmax'],
                'confidence': 0.72
            })

        # Rank by confidence and impact
        ranked_issues = self.rank_issues(issues, sensitivity_analysis_results)

        return ranked_issues
```

**Sensitivity Analysis**:

```r
# Identify influential parameters
library(ospsuite)

parameters_to_test <- c(
  "Compound|Permeability",
  "Compound|Lipophilicity",
  "Compound|Specific clearance",
  "Compound|Km"
)

# Local sensitivity analysis
sensitivity_results <- calculateSensitivity(
  simulation = sim,
  parameterPaths = parameters_to_test,
  observerPath = "Organism|PeripheralVenousBlood|Plasma",
  variationRange = 0.1  # ±10% variation
)

# Rank by impact on AUC
ranked_params <- rank_by_impact(sensitivity_results, metric = "AUC")
print(ranked_params)
# Output: [Clearance (impact: 0.92), Permeability (impact: 0.45), ...]
```

**AI Recommendations**:
```
DIAGNOSIS SUMMARY (Model v1.5)
================================

FINDING 1 (High Confidence)
---------------------------
Issue: Consistent underprediction of Cmax in fed state studies
Likely cause: First-pass metabolism overestimated
Suggested action: Reduce intestinal CYP3A4 Vmax by 30-50%
Supporting evidence:
  - 5/6 fed state studies show Cmax underprediction
  - Fasted state studies adequately predicted
  - Similar pattern observed in [Literature Reference]

FINDING 2 (Medium Confidence)
------------------------------
Issue: Faster elimination than observed in Study 3
Likely cause: Renal clearance overestimated
Suggested action: Review GFR fraction, consider protein binding effect
Supporting evidence:
  - Terminal half-life: observed 8.2h, predicted 5.3h
  - Sensitivity analysis: High impact of renal clearance

RECOMMENDED REFINEMENT PRIORITY:
1. Intestinal metabolism (Issue 1) - High impact
2. Renal clearance (Issue 2) - Medium impact
```

#### Step 4: Decide (Human Expert)

**Expert Review Checklist**:

- [ ] Review AI-generated diagnosis
- [ ] Assess mechanistic plausibility of suggested changes
- [ ] Verify that suggested parameters are identifiable from data
- [ ] Check that parameter changes remain within physiological bounds
- [ ] Decide on refinement strategy:
  - [ ] Manual parameter adjustment
  - [ ] Automated optimization with constraints
  - [ ] Structural model modification (MoBi)
- [ ] Define stopping criteria for optimization
- [ ] Approve proceeding to refinement step

**Decision Documentation**:
```yaml
refinement_decision:
  iteration: 2
  date: 2024-03-15
  reviewer: Dr. Jane Smith

  diagnosis_review:
    - finding: "Underprediction of Cmax in fed state"
      assessment: "Agree - consistent pattern across studies"
      action: "Approved for refinement"

    - finding: "Faster elimination in Study 3"
      assessment: "Partially agree - could also be population variability"
      action: "Conduct population simulation before parameter change"

  refinement_strategy:
    method: "Automated optimization"
    parameters_to_fit:
      - name: "Intestinal CYP3A4 Vmax"
        bounds: [0.5, 2.0]  # Fold change from current value
      - name: "GFR fraction"
        bounds: [0.0, 1.0]

    constraints:
      - "Total clearance must remain within 10-30 L/h"
      - "Vss must remain within 50-150 L"

    acceptance_criteria:
      - "GMFE < 1.8"
      - "90% of points within 2-fold"
```

#### Step 5: Refine

**Automated Parameter Optimization**:

```r
library(ospsuite.parameteridentification)

# Configure optimization based on expert decision
optimization_config <- createOptimizationConfiguration(
  algorithm = "Levenberg-Marquardt",
  tolerance = 1e-3,
  max_iterations = 100,
  run_in_parallel = TRUE
)

# Define parameters with bounds (from expert decision)
params_to_fit <- list(
  createOptimizationParameter(
    path = "Organism|SmallIntestine|CYP3A4|Vmax",
    startValue = current_value,
    min = current_value * 0.5,
    max = current_value * 2.0
  ),
  createOptimizationParameter(
    path = "Compound|GFR fraction",
    startValue = 0.5,
    min = 0.0,
    max = 1.0
  )
)

# Run optimization
optimization_result <- runParameterIdentification(
  simulation = sim,
  parameters = params_to_fit,
  observedData = all_observed_data,
  configuration = optimization_config
)

# Apply optimized parameters
updated_sim <- applyOptimizationResult(sim, optimization_result)

# Save updated model
saveSimulation(updated_sim, "CompoundX_v1.6.pkml")
```

**AI Monitoring**:
```python
# AI agent monitors optimization progress
def monitor_optimization(optimization_run):
    for iteration in optimization_run:
        # Check convergence
        if iteration.improvement < threshold:
            alert("Optimization converging slowly")

        # Check constraint violations
        if check_constraints_violated(iteration.parameters):
            alert("Parameters exceeding physiological bounds")
            recommend_constraint_adjustment()

        # Check for local minima
        if detect_local_minimum(iteration.history):
            recommend_restart_with_different_initial_values()

    # Final validation
    validate_optimized_parameters(optimization_run.final_parameters)
```

**Constraint Enforcement**:
```r
# Define physiological constraints
constraints <- list(
  # Total clearance constraint
  constraint_total_clearance = function(params) {
    CL_total <- calculate_total_clearance(params)
    return(CL_total >= 10 && CL_total <= 30)
  },

  # Vss constraint
  constraint_vss = function(params) {
    Vss <- calculate_vss(params)
    return(Vss >= 50 && Vss <= 150)
  }
)

# Apply during optimization
optimization_config$constraints <- constraints
```

#### Step 6: Document

**Automated Documentation**:

```python
class ModelDocumentationAgent:
    def document_refinement_iteration(self, iteration_data):
        """
        Generate comprehensive documentation for model refinement
        """
        doc = {
            'iteration': iteration_data['iteration_number'],
            'date': datetime.now().isoformat(),
            'model_version': iteration_data['model_version'],

            'changes': {
                'parameters_modified': self._list_parameter_changes(
                    iteration_data['old_params'],
                    iteration_data['new_params']
                ),
                'structural_changes': iteration_data.get('structural_changes', None)
            },

            'rationale': {
                'diagnosis': iteration_data['diagnosis'],
                'expert_decision': iteration_data['expert_decision'],
                'optimization_method': iteration_data['optimization_method']
            },

            'performance': {
                'previous_gof': iteration_data['previous_gof'],
                'current_gof': iteration_data['current_gof'],
                'improvement': self._calculate_improvement(
                    iteration_data['previous_gof'],
                    iteration_data['current_gof']
                )
            },

            'validation': {
                'constraints_satisfied': iteration_data['constraints_check'],
                'physiological_plausibility': iteration_data['plausibility_check']
            }
        }

        # Save to Git
        self.save_to_version_control(doc)

        # Generate human-readable summary
        summary = self._generate_narrative_summary(doc)

        return summary

    def _generate_narrative_summary(self, doc):
        """
        Generate human-readable summary using LLM
        """
        template = f"""
        Model Refinement Summary - Iteration {doc['iteration']}

        CHANGES MADE:
        {self._format_parameter_changes(doc['changes']['parameters_modified'])}

        RATIONALE:
        {doc['rationale']['diagnosis']}

        The expert decided to {doc['rationale']['expert_decision']}.
        Optimization was performed using {doc['rationale']['optimization_method']}.

        PERFORMANCE IMPROVEMENT:
        - Previous GMFE: {doc['performance']['previous_gof']['GMFE']:.2f}
        - Current GMFE: {doc['performance']['current_gof']['GMFE']:.2f}
        - Improvement: {doc['performance']['improvement']:.1f}%

        VALIDATION:
        All physiological constraints satisfied: {doc['validation']['constraints_satisfied']}
        Model remains physiologically plausible: {doc['validation']['physiological_plausibility']}

        NEXT STEPS:
        {self._recommend_next_steps(doc)}
        """

        return template
```

**Version Control**:
```bash
# AI agent commits changes
git add CompoundX_v1.6.pkml
git add refinement_log_iteration2.json
git commit -m "Iteration 2: Optimized intestinal metabolism and renal clearance

- Reduced intestinal CYP3A4 Vmax by 38%
- Adjusted GFR fraction to 0.72
- GMFE improved from 1.85 to 1.42
- All constraints satisfied"

git tag v1.6 -m "Model version 1.6 - Improved fed state predictions"
```

### Stopping Criteria

**When to Stop Iterating**:

1. **Performance-Based**:
   - GOF metrics meet acceptance criteria
   - No further improvement in last 2-3 iterations
   - Diminishing returns (improvement < 5%)

2. **Practical**:
   - Time/resource budget exhausted
   - Model complexity becoming excessive
   - Parameter identifiability issues emerging

3. **Scientific**:
   - Model predictions conflict with known physiology
   - Mechanistic implausibility
   - Overfitting concerns

**AI Decision Support**:
```python
def should_stop_refinement(refinement_history):
    """
    AI agent recommends whether to continue or stop refinement
    """
    latest_iteration = refinement_history[-1]

    # Check acceptance criteria
    if meets_acceptance_criteria(latest_iteration['gof']):
        return True, "Acceptance criteria met"

    # Check for convergence
    if len(refinement_history) >= 3:
        recent_improvements = [
            calc_improvement(refinement_history[i-1], refinement_history[i])
            for i in range(-3, 0)
        ]
        if all(imp < 0.05 for imp in recent_improvements):
            return True, "Convergence reached - minimal improvement"

    # Check for overfitting risk
    if detect_overfitting_risk(refinement_history):
        return True, "Risk of overfitting - model complexity increasing"

    # Check parameter identifiability
    if not check_identifiability(latest_iteration['parameters']):
        return True, "Parameter identifiability concerns"

    return False, "Continue refinement"
```

---

## Quality Assurance and Validation

### Model Validation Levels

#### Level 1: Internal Validation

**Training Data Fit**:
- Data used for parameter estimation
- Should show good fit (expected)
- Not sufficient alone for validation

**AI Support**:
- Automated GOF calculation
- Residual analysis
- Outlier detection

#### Level 2: External Validation

**Independent Test Data**:
- Data NOT used for parameter estimation
- Different doses, routes, or populations
- Stronger evidence of model validity

**Validation Strategy**:
```r
# Separate training and validation datasets
training_studies <- c("Study1", "Study2", "Study3")
validation_studies <- c("Study4", "Study5")

# Fit model on training data only
optimized_model <- fit_model(
  simulation = sim,
  data = training_data
)

# Validate on external data
validation_results <- validate_model(
  model = optimized_model,
  validation_data = validation_data
)

# Check if validation performance is acceptable
if (validation_results$GMFE < 2.0) {
  print("External validation successful")
} else {
  print("Model does not generalize well - revisit model structure")
}
```

**AI Validation Agent**:
```python
def perform_external_validation(model, validation_data):
    """
    AI agent conducts external validation
    """
    # Run simulations
    predictions = simulate_validation_scenarios(model, validation_data)

    # Calculate metrics
    metrics = calculate_gof(validation_data, predictions)

    # Compare to training performance
    if metrics['GMFE'] > training_metrics['GMFE'] * 1.5:
        alert("Model may be overfitted - large gap between training and validation")
        recommend_model_simplification()

    # Generate validation report
    report = generate_validation_report(metrics, predictions, validation_data)

    return report
```

#### Level 3: Qualification

**Purpose**: Demonstrate model is fit-for-purpose for specific application

**Documentation**: https://docs.open-systems-pharmacology.org/shared-tools-and-example-workflows/qualification

**Qualification Plan Components**:

1. **Introduction**:
   - Model purpose and scope
   - Modeling approach
   - Intended use cases

2. **Methods**:
   - Software versions
   - Model structure
   - Parameter sources
   - Validation datasets

3. **Results**:
   - Performance across all scenarios
   - Summary statistics
   - Plots (obs vs pred, time profiles)

4. **Conclusion**:
   - Model strengths and limitations
   - Appropriate use cases
   - Uncertainty quantification

**AI-Assisted Qualification**:

```r
# Generate qualification plan
library(ospsuite.qualificationplaneditor)

qualification_plan <- createQualificationPlan(
  title = "CompoundX PBPK Model Qualification",
  version = "1.0"
)

# Add projects
addProjects(qualification_plan,
  projects = list.files("./simulations", pattern = ".pkml$")
)

# Add observed data
addObservedData(qualification_plan,
  data = list.files("./data", pattern = ".csv$")
)

# Define plots
addPlots(qualification_plan, plot_configuration = "standard_plots.json")

# Generate report
exportQualificationPlan(qualification_plan, "./qualification/plan.json")

# Run qualification (via CLI)
system("qualification-runner --input ./qualification/plan.json --output ./qualification/report")
```

**AI Report Enhancement**:
```python
def enhance_qualification_report(auto_generated_report):
    """
    AI adds narrative and interpretation to qualification report
    """
    enhanced_report = auto_generated_report.copy()

    # Add executive summary
    enhanced_report['executive_summary'] = generate_executive_summary(
        performance_metrics=auto_generated_report['summary_stats'],
        model_scope=auto_generated_report['introduction']
    )

    # Add interpretation for each section
    for section in enhanced_report['results']:
        section['interpretation'] = interpret_results(section['data'])

    # Add limitations section
    enhanced_report['limitations'] = identify_limitations(
        performance_data=auto_generated_report['results'],
        model_structure=auto_generated_report['methods']
    )

    # Add recommendations
    enhanced_report['recommendations'] = generate_recommendations(
        performance=auto_generated_report['summary_stats'],
        limitations=enhanced_report['limitations']
    )

    return enhanced_report
```

### Sensitivity and Uncertainty Analysis

#### Global Sensitivity Analysis

**Purpose**: Identify which parameters most influence model outputs

```r
library(ospsuite.globalsensitivity)

# Define parameter ranges (based on uncertainty)
param_ranges <- data.frame(
  parameter = c("Permeability", "Lipophilicity", "CL_liver", "Vss"),
  min = c(1e-6, 0.5, 5, 50),
  max = c(1e-4, 4.0, 30, 200),
  distribution = c("uniform", "uniform", "uniform", "uniform")
)

# Sobol sensitivity analysis
sobol_results <- run_sobol_analysis(
  simulation = sim,
  parameters = param_ranges,
  output = "Plasma|AUC",
  n_samples = 1000
)

# First-order sensitivity indices
print(sobol_results$S1)
# Output:
# CL_liver: 0.65 (most influential)
# Vss: 0.20
# Permeability: 0.10
# Lipophilicity: 0.05
```

**AI Interpretation**:
```python
def interpret_sensitivity_analysis(sensitivity_results):
    """
    AI interprets sensitivity analysis results
    """
    interpretation = {
        'influential_parameters': [],
        'recommendations': []
    }

    # Identify highly influential parameters
    for param, sensitivity_index in sensitivity_results['S1'].items():
        if sensitivity_index > 0.3:
            interpretation['influential_parameters'].append({
                'parameter': param,
                'sensitivity': sensitivity_index,
                'implication': f"{param} strongly influences model output. "
                               f"Ensure this parameter is well-characterized."
            })

    # Recommendations
    if any(si > 0.5 for si in sensitivity_results['S1'].values()):
        interpretation['recommendations'].append(
            "Focus validation efforts on highly sensitive parameters"
        )

    return interpretation
```

#### Uncertainty Quantification

**Monte Carlo Simulation**:

```r
# Propagate parameter uncertainty to output uncertainty
n_iterations <- 1000

# Sample from parameter distributions
param_samples <- sample_parameter_distributions(
  parameters = param_ranges,
  n_samples = n_iterations,
  method = "latin_hypercube"
)

# Run simulations for each sample
results_distribution <- lapply(1:n_iterations, function(i) {
  # Update parameters
  setParameterValues(sim, param_samples[i, ])

  # Run simulation
  result <- runSimulation(sim)

  # Extract outputs
  extract_pK_parameters(result)
})

# Calculate prediction intervals
prediction_intervals <- calculate_percentiles(
  results_distribution,
  percentiles = c(0.05, 0.25, 0.50, 0.75, 0.95)
)

# Visualize uncertainty
plot_prediction_intervals(
  observed = observed_data,
  median = prediction_intervals$p50,
  lower = prediction_intervals$p05,
  upper = prediction_intervals$p95
)
```

**AI Uncertainty Analysis**:
```python
def analyze_prediction_uncertainty(prediction_intervals, observed_data):
    """
    AI evaluates whether prediction intervals adequately capture uncertainty
    """
    analysis = {}

    # Check coverage
    obs_within_90PI = calculate_coverage(
        observed_data,
        lower=prediction_intervals['p05'],
        upper=prediction_intervals['p95']
    )

    analysis['coverage'] = {
        'percentage': obs_within_90PI * 100,
        'expected': 90,
        'assessment': 'Adequate' if obs_within_90PI > 0.85 else 'Inadequate'
    }

    # Width of prediction intervals
    interval_width = (prediction_intervals['p95'] - prediction_intervals['p05'])

    if interval_width.mean() > observed_data.mean():
        analysis['precision'] = {
            'assessment': 'Low',
            'recommendation': 'Consider collecting additional data to reduce parameter uncertainty'
        }

    return analysis
```

### Cross-Validation

**K-Fold Cross-Validation**:

```python
def perform_cross_validation(simulation, all_data, k=5):
    """
    AI agent performs k-fold cross-validation
    """
    from sklearn.model_selection import KFold

    kf = KFold(n_splits=k, shuffle=True, random_state=42)
    fold_results = []

    for fold, (train_idx, test_idx) in enumerate(kf.split(all_data)):
        print(f"Processing fold {fold + 1}/{k}")

        # Split data
        train_data = all_data[train_idx]
        test_data = all_data[test_idx]

        # Fit model on training fold
        fitted_model = fit_model(simulation, train_data)

        # Evaluate on test fold
        predictions = simulate(fitted_model, test_data)
        gof = calculate_gof(test_data, predictions)

        fold_results.append({
            'fold': fold,
            'train_size': len(train_idx),
            'test_size': len(test_idx),
            'gof': gof
        })

    # Aggregate results
    avg_gof = np.mean([r['gof']['GMFE'] for r in fold_results])
    std_gof = np.std([r['gof']['GMFE'] for r in fold_results])

    report = {
        'mean_GMFE': avg_gof,
        'std_GMFE': std_gof,
        'cv_GMFE': std_gof / avg_gof,  # Coefficient of variation
        'assessment': 'Robust' if std_gof / avg_gof < 0.2 else 'Variable'
    }

    return report
```

---

## Documentation and Reporting

### Documentation Levels

#### 1. Internal Documentation (Version Control)

**Git Repository Structure**:
```
CompoundX_PBPK_Model/
├── README.md
├── models/
│   ├── CompoundX_v1.0.pkml
│   ├── CompoundX_v1.5.pkml
│   ├── CompoundX_v2.0.pkml (final)
│   └── snapshots/
│       ├── CompoundX_v1.0.json
│       ├── CompoundX_v1.5.json
│       └── CompoundX_v2.0.json
├── data/
│   ├── observed/
│   │   ├── study1_pk_data.csv
│   │   ├── study2_pk_data.csv
│   │   └── metadata.json
│   └── predicted/
│       └── simulation_results_v2.0.csv
├── scripts/
│   ├── setup_model.R
│   ├── parameter_optimization.R
│   ├── sensitivity_analysis.R
│   └── generate_report.R
├── refinement_log/
│   ├── iteration_01.json
│   ├── iteration_02.json
│   └── iteration_03.json
├── reports/
│   ├── qualification_report.md
│   └── figures/
├── validation/
│   ├── qualification_plan.json
│   └── external_validation_results.csv
└── .gitignore
```

**Refinement Log Format**:
```json
{
  "iteration": 2,
  "date": "2024-03-15T14:30:00Z",
  "model_version": "v1.5",
  "previous_version": "v1.4",

  "diagnosis": {
    "issue": "Underprediction of Cmax in fed state",
    "likely_cause": "Intestinal metabolism overestimated",
    "confidence": 0.85
  },

  "changes": {
    "parameters": [
      {
        "path": "Organism|SmallIntestine|CYP3A4|Vmax",
        "old_value": 150,
        "new_value": 93,
        "units": "nmol/min",
        "change_percentage": -38,
        "rationale": "Optimization to improve fed state predictions"
      }
    ]
  },

  "performance": {
    "previous": {
      "GMFE": 1.85,
      "percentage_within_2fold": 82
    },
    "current": {
      "GMFE": 1.42,
      "percentage_within_2fold": 91
    },
    "improvement": 23.2
  },

  "validation": {
    "constraints_satisfied": true,
    "physiologically_plausible": true,
    "expert_reviewed": true,
    "reviewer": "Dr. Jane Smith"
  },

  "next_steps": "Continue to iteration 3 - address Study 3 elimination discrepancy"
}
```

#### 2. Model Evaluation Report

**AI-Generated Report Structure**:

```markdown
# CompoundX PBPK Model Evaluation Report

## Executive Summary

A whole-body PBPK model for CompoundX was developed using PK-Sim and refined
through 3 iterations. The final model (v2.0) adequately describes the
pharmacokinetics of CompoundX in healthy adults following intravenous and
oral administration. Model performance metrics (GMFE = 1.38) meet pre-defined
acceptance criteria. The model has been externally validated and qualified
for use in dose selection and formulation bridging applications.

## Model Overview

**Compound**: CompoundX
**Indication**: [Therapeutic area]
**Modeling Objective**: Support dose selection for Phase 2 studies
**Software**: PK-Sim v12.2, MoBi v12.2, ospsuite-R v12.2
**Model Version**: 2.0 (Final)
**Date**: 2024-03-20

## Methods

### Model Structure

- **Type**: Whole-body PBPK, small molecule
- **Species**: Human
- **Organs**: Standard PBPK organs (brain, heart, kidney, liver, etc.)
- **Distribution Model**: PK-Sim Standard
- **Elimination**:
  - Hepatic metabolism (CYP3A4, CYP2D6)
  - Renal clearance (glomerular filtration)

### Parameter Sources

| Parameter | Value | Units | Source | Uncertainty |
|-----------|-------|-------|--------|-------------|
| MW | 350.5 | g/mol | Experimental | - |
| LogP | 2.8 | - | Experimental | ±0.2 |
| fu | 0.15 | - | In vitro (UF) | ±30% |
| Permeability | 3.5e-5 | cm/min | In vitro (Caco-2) | ±50% |
| CLint,CYP3A4 | 45 | µL/min/pmol | In vitro (HLM) | ±50% |
| GFR fraction | 0.72 | - | Optimized | - |

### Observed Data

| Study | Design | Dose | Route | N | Population | Use |
|-------|--------|------|-------|---|------------|-----|
| Study 1 | SAD | 100 mg | IV | 8 | HV | Training |
| Study 2 | SAD | 200 mg | PO | 12 | HV | Training |
| Study 3 | MAD | 50 mg BID | PO | 16 | Pediatric | Training |
| Study 4 | Food Effect | 200 mg | PO | 12 | HV | Validation |
| Study 5 | DDI | 200 mg | PO | 12 | HV + Keto | Validation |

**HV: Healthy Volunteers; SAD: Single Ascending Dose; MAD: Multiple Ascending Dose**

### Model Refinement Process

The model underwent 3 refinement iterations:

**Iteration 1**: Initial model setup with predicted parameters
- Performance: GMFE = 2.15
- Issue: Poor absorption predictions

**Iteration 2**: Optimized permeability and intestinal metabolism
- Performance: GMFE = 1.42
- Issue: Elimination phase in pediatrics

**Iteration 3**: Adjusted pediatric CYP3A4 ontogeny
- Performance: GMFE = 1.38
- Result: All acceptance criteria met ✓

## Results

### Model Performance (Training Data)

**Overall Statistics**:
- GMFE: 1.38
- % within 1.5-fold: 78%
- % within 2-fold: 95%
- RMSE: 18.3 ng/mL

[Insert goodness-of-fit plots]

### External Validation

**Study 4 (Food Effect)**:
- GMFE: 1.52
- Model correctly predicted increased AUC in fed state

**Study 5 (DDI with Ketoconazole)**:
- GMFE: 1.48
- Predicted AUC ratio: 3.2x (Observed: 3.5x)

### Sensitivity Analysis

Most influential parameters (Sobol first-order indices):
1. Hepatic clearance: S1 = 0.68
2. Volume of distribution: S1 = 0.22
3. Intestinal permeability: S1 = 0.08

### Uncertainty Analysis

90% prediction interval coverage: 88% (adequate)

[Insert prediction interval plots]

## Discussion

### Model Strengths
- Adequate performance across diverse scenarios
- Successful external validation
- Mechanistic basis allows extrapolation
- Uncertainty well-characterized

### Model Limitations
- Limited data in special populations (only one pediatric study)
- DDI validation limited to CYP3A4 inhibition
- No data with hepatic/renal impairment

### Recommended Applications
✓ Dose selection for Phase 2
✓ Formulation bridging
✓ CYP3A4 DDI predictions
⚠ Pediatric dosing (use with caution - limited data)
✗ Hepatic impairment (insufficient data)

## Conclusion

The CompoundX PBPK model is qualified for use in dose selection and
formulation bridging applications. External validation and sensitivity
analyses support model robustness. Future refinements should focus on
collecting additional pediatric and special population data.

## Appendices

### A. Software Versions
- PK-Sim: 12.2
- MoBi: 12.2
- ospsuite-R: 12.2.0
- R: 4.3.0

### B. Model Files
- Model: `CompoundX_v2.0.pkml`
- Snapshot: `CompoundX_v2.0.json`
- Repository: [GitHub link]

### C. References
[Literature references]
```

**AI Report Generation**:

```r
library(ospsuite.reportingengine)

# Configure report
report_config <- createReportConfiguration(
  title = "CompoundX PBPK Model Evaluation",
  author = "AI-Assisted Modeling Team",
  output_format = "docx",
  template = "pbpk_evaluation_template.docx"
)

# Add sections
addSection(report_config, "executive_summary",
  content = ai_generated_summary
)

addSection(report_config, "methods",
  model_description = model_info,
  parameter_table = parameter_df,
  data_description = study_info
)

addSection(report_config, "results",
  gof_plots = list.files("./figures/gof", pattern = ".png"),
  performance_tables = performance_metrics,
  sensitivity_analysis = sensitivity_results
)

addSection(report_config, "discussion",
  content = ai_generated_discussion,
  limitations = ai_identified_limitations,
  recommendations = ai_recommendations
)

# Generate report
generateReport(report_config, output_path = "./reports/CompoundX_Evaluation.docx")
```

#### 3. Model Repository (for Sharing)

**Documentation**: See CREATING_MODEL_REPOSITORY.md

**Repository Structure** (following OSP standards):
```
CompoundX-Model/  (GitHub repository)
├── README.md  (Model overview, key results)
├── CompoundX.json  (PK-Sim snapshot)
├── Evaluation/
│   ├── Input/
│   │   ├── CompoundX.pkml
│   │   └── observed_data/
│   ├── evaluation_plan.json
│   └── evaluation_report.md
└── LICENSE
```

**AI-Assisted Repository Creation**:

```python
class ModelRepositoryAgent:
    def create_repository(self, model_info):
        """
        AI agent creates model repository following OSP standards
        """
        # Create README
        readme_content = self.generate_readme(
            compound_name=model_info['compound'],
            model_version=model_info['version'],
            performance_metrics=model_info['metrics'],
            applications=model_info['recommended_uses']
        )

        # Export snapshot
        snapshot_path = self.export_snapshot(model_info['model_path'])

        # Create evaluation plan
        eval_plan = self.create_evaluation_plan(
            simulations=model_info['simulations'],
            observed_data=model_info['observed_data']
        )

        # Generate evaluation report
        eval_report = self.generate_evaluation_report(
            model=model_info['model'],
            validation_results=model_info['validation_results']
        )

        # Package for GitHub
        repo_bundle = {
            'README.md': readme_content,
            'CompoundX.json': snapshot_path,
            'Evaluation/evaluation_plan.json': eval_plan,
            'Evaluation/evaluation_report.md': eval_report
        }

        return repo_bundle

    def generate_readme(self, compound_name, model_version,
                       performance_metrics, applications):
        """
        Generate README following OSP template
        """
        template = f"""
# {compound_name} PBPK Model

## Repository Description

Whole-body PBPK model of {compound_name} developed using PK-Sim.

## Model Version
{model_version}

## Model Performance

| Metric | Value |
|--------|-------|
| GMFE | {performance_metrics['GMFE']:.2f} |
| % within 2-fold | {performance_metrics['pct_within_2fold']:.0f}% |

## Recommended Applications

{self._format_applications_list(applications)}

## Model Files

- `{compound_name}.json`: PK-Sim project snapshot
- `Evaluation/`: Model evaluation plan and report

## License

GPLv2

## Contact

[Maintainer information]
        """
        return template
```

### Regulatory Documentation

For regulatory submissions (IND, NDA, MAA), additional documentation is required:

#### Model Development Report

**Structure** (following FDA/EMA guidelines):
1. **Executive Summary**
2. **Introduction**
   - Regulatory context
   - Modeling objectives
   - Intended use of model
3. **Model Development**
   - Model structure selection and justification
   - Parameter estimation methods
   - Software validation
4. **Model Evaluation**
   - Goodness-of-fit
   - Sensitivity analysis
   - Uncertainty quantification
   - External validation
5. **Model Application**
   - Scenario simulations
   - Conclusions and recommendations
6. **Appendices**
   - Detailed methods
   - Complete results
   - Software validation documentation

**AI Support for Regulatory Documentation**:

```python
def generate_regulatory_report(model_data, regulatory_context):
    """
    AI generates regulatory-compliant model report
    """
    # Select appropriate template based on agency
    if regulatory_context['agency'] == 'FDA':
        template = load_template('fda_pbpk_report_template')
    elif regulatory_context['agency'] == 'EMA':
        template = load_template('ema_pbpk_report_template')

    # Generate sections with appropriate level of detail
    report = {}

    # Executive summary (1-2 pages)
    report['executive_summary'] = generate_executive_summary(
        model_data, max_length=2_pages
    )

    # Introduction with regulatory context
    report['introduction'] = generate_introduction(
        objectives=model_data['objectives'],
        regulatory_guidelines=get_relevant_guidelines(regulatory_context),
        precedents=find_similar_regulatory_submissions(model_data['compound'])
    )

    # Detailed methods following regulatory expectations
    report['methods'] = generate_methods_section(
        model_data=model_data,
        detail_level='regulatory',  # More detail than internal reports
        include_validation=True,
        include_assumptions=True
    )

    # Results with focus on validation
    report['results'] = generate_results_section(
        performance_data=model_data['performance'],
        validation_data=model_data['validation'],
        emphasize_external_validation=True
    )

    # Application section (scenario simulations)
    report['application'] = generate_application_section(
        simulations=model_data['scenarios'],
        recommendations=model_data['recommendations'],
        limitations=model_data['limitations']
    )

    # Compliance check
    compliance_check = verify_regulatory_compliance(
        report, regulatory_context['agency']
    )

    if not compliance_check['compliant']:
        report = add_missing_sections(report, compliance_check['missing'])

    return report
```

---

## Implementation Roadmap

### Phase 1: Foundation (Months 1-3)

**Objective**: Establish basic AI-assisted workflow

#### Month 1: Infrastructure Setup

**Tasks**:
- [ ] Set up version control (Git/GitHub)
- [ ] Install OSP Suite (PK-Sim, MoBi, R packages)
- [ ] Configure development environment
- [ ] Establish project templates
- [ ] Create standard operating procedures (SOPs)

**AI Integration**:
- [ ] Set up LLM API access (GPT-4, Claude, etc.)
- [ ] Configure AI development environment
- [ ] Test basic AI capabilities (literature search, code generation)

**Deliverables**:
- Configured computing environment
- Project template repository
- Basic AI integration test results

#### Month 2: Data Infrastructure

**Tasks**:
- [ ] Develop data collection templates
- [ ] Create database schema for model parameters
- [ ] Build data validation pipeline
- [ ] Establish observed data repository

**AI Integration**:
- [ ] Develop AI data extraction tools (literature mining)
- [ ] Create automated data quality checks
- [ ] Build data format conversion utilities

**Deliverables**:
- Data collection templates
- AI-powered data extraction prototype
- Data validation pipeline

#### Month 3: Basic Workflow Implementation

**Tasks**:
- [ ] Implement automated model setup (PK-Sim)
- [ ] Create R scripts for batch simulation
- [ ] Develop goodness-of-fit calculation tools
- [ ] Build basic reporting framework

**AI Integration**:
- [ ] AI-assisted parameter prediction
- [ ] Automated literature search for compound properties
- [ ] AI-generated R scripts

**Deliverables**:
- Basic AI-assisted workflow (end-to-end)
- Example model created using workflow
- Initial performance evaluation

### Phase 2: Enhancement (Months 4-6)

**Objective**: Add advanced AI capabilities

#### Month 4: Intelligent Model Refinement

**Tasks**:
- [ ] Implement parameter optimization framework
- [ ] Develop sensitivity analysis tools
- [ ] Create diagnostic agents for model evaluation

**AI Integration**:
- [ ] Build diagnostic AI agent
- [ ] Implement AI-guided parameter optimization
- [ ] Develop pattern recognition for residual analysis

**Deliverables**:
- Diagnostic AI agent (prototype)
- Parameter optimization toolkit
- Refinement workflow documentation

#### Month 5: Advanced Analytics

**Tasks**:
- [ ] Implement uncertainty quantification
- [ ] Develop population simulation workflows
- [ ] Create scenario simulation framework

**AI Integration**:
- [ ] AI-driven sensitivity analysis
- [ ] Automated scenario generation
- [ ] Uncertainty interpretation agent

**Deliverables**:
- Uncertainty quantification tools
- AI-enhanced analytics suite
- Example applications

#### Month 6: Reporting and Documentation

**Tasks**:
- [ ] Develop automated report generation
- [ ] Create qualification plan templates
- [ ] Build model repository creator

**AI Integration**:
- [ ] AI report writer (narrative generation)
- [ ] Automated figure selection and captioning
- [ ] Intelligent documentation agent

**Deliverables**:
- Automated reporting system
- Qualification framework integration
- Complete documentation toolkit

### Phase 3: Validation and Deployment (Months 7-9)

**Objective**: Validate AI workflow and deploy for routine use

#### Month 7: Workflow Validation

**Tasks**:
- [ ] Conduct pilot projects (2-3 compounds)
- [ ] Compare AI-assisted vs. traditional workflow
- [ ] Gather user feedback
- [ ] Refine based on lessons learned

**AI Integration**:
- [ ] Validate AI predictions against expert decisions
- [ ] Measure AI performance metrics
- [ ] Optimize AI prompts and parameters

**Deliverables**:
- Validation report (workflow performance)
- User feedback summary
- Refined workflow (v2.0)

#### Month 8: Training and Documentation

**Tasks**:
- [ ] Create user training materials
- [ ] Develop troubleshooting guides
- [ ] Write best practices document
- [ ] Conduct training sessions

**AI Integration**:
- [ ] Create AI assistant user guide
- [ ] Document AI limitations and appropriate use
- [ ] Develop AI troubleshooting guide

**Deliverables**:
- Comprehensive user documentation
- Training materials
- Video tutorials

#### Month 9: Full Deployment

**Tasks**:
- [ ] Deploy to production environment
- [ ] Establish support structure
- [ ] Implement monitoring and metrics
- [ ] Begin routine use on projects

**AI Integration**:
- [ ] Production AI system deployment
- [ ] Monitoring dashboard for AI performance
- [ ] Feedback collection system

**Deliverables**:
- Production-ready AI-assisted PBPK workflow
- Support and maintenance plan
- Metrics dashboard

### Phase 4: Continuous Improvement (Month 10+)

**Objective**: Maintain and enhance system based on experience

**Ongoing Activities**:
- [ ] Monitor workflow performance
- [ ] Collect user feedback
- [ ] Update AI models with new data
- [ ] Expand capabilities (new use cases)
- [ ] Stay current with OSP Suite updates
- [ ] Incorporate new AI technologies

**Key Metrics to Track**:
- Time savings vs. traditional workflow
- Model quality (GOF metrics)
- User satisfaction
- AI prediction accuracy
- Error rates and types

---

## Appendix A: Tool Reference Guide

### OSP Suite Tools

| Tool | Purpose | Documentation |
|------|---------|---------------|
| PK-Sim | Whole-body PBPK model building | https://docs.open-systems-pharmacology.org/working-with-pk-sim/pk-sim-documentation |
| MoBi | Advanced model customization | https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation |
| ospsuite (R) | Scripted simulation workflows | https://www.open-systems-pharmacology.org/OSPSuite-R/ |
| ospsuite.parameteridentification | Parameter optimization | https://github.com/Open-Systems-Pharmacology/OSPSuite.ParameterIdentification |
| ospsuite.reportingengine | Automated reports | https://www.open-systems-pharmacology.org/OSPSuite.ReportingEngine/ |
| tlf | Standardized plots | https://www.open-systems-pharmacology.org/TLF-Library/ |
| Qualification Framework | Model validation | https://docs.open-systems-pharmacology.org/shared-tools-and-example-workflows/qualification |

### AI/ML Tools

| Tool | Purpose | Access |
|------|---------|--------|
| GPT-4 | General-purpose LLM, code generation | OpenAI API |
| Claude | Scientific reasoning, long-context | Anthropic API |
| PubMed AI / Elicit | Literature search and extraction | Web / API |
| DeepChem | ADME property prediction | Open source |
| LangChain | AI agent framework | Open source |
| MLflow | Experiment tracking | Open source |

## Appendix B: Glossary

**ADME**: Absorption, Distribution, Metabolism, Excretion

**AFE**: Average Fold Error - measure of prediction bias

**GMFE**: Geometric Mean Fold Error - primary goodness-of-fit metric for PBPK

**GOF**: Goodness-of-Fit - comparison of model predictions vs. observations

**HITL**: Human-In-The-Loop - workflow with AI automation and human oversight

**LLM**: Large Language Model - AI system trained on text data

**NLP**: Natural Language Processing - AI processing of human language

**PBPK**: Physiologically-Based Pharmacokinetic modeling

**PKML**: PK Modeling Language - OSP model exchange format

**QSAR**: Quantitative Structure-Activity Relationship - predicting properties from chemical structure

**Snapshot**: JSON export of PK-Sim project (version control friendly)

**TMDD**: Target-Mediated Drug Disposition - PK influenced by target binding

---

## Appendix C: Example AI Agent Prompts

### Prompt 1: Initial Model Setup

```
You are a PBPK modeling assistant. Help me set up a PBPK model for CompoundX.

Compound Information:
- Name: CompoundX
- MW: 350.5 g/mol
- LogP: 2.8
- Compound type: Small molecule, weak base (pKa = 8.2)

Available Data:
- In vitro: Caco-2 permeability, HLM clearance, plasma protein binding
- Clinical: Single dose PK study (100 mg IV, 200 mg PO)

Tasks:
1. Search literature for any additional ADME data for CompoundX
2. Predict any missing physicochemical parameters
3. Generate R script to create PK-Sim individual and compound
4. List assumptions made and their justifications

Provide code, explanations, and flag any areas needing expert review.
```

### Prompt 2: Model Diagnostics

```
You are a PBPK model diagnostic agent. Analyze the following model performance:

Observed vs. Predicted:
[Paste GOF metrics and residual plots]

Task:
1. Identify patterns in residuals
2. Suggest most likely causes of discrepancies
3. Recommend parameters to adjust
4. Provide R code for sensitivity analysis of suggested parameters

Consider mechanistic plausibility in your recommendations.
```

### Prompt 3: Report Generation

```
You are a technical writer specializing in PBPK modeling reports.

Generate the Discussion section for a model evaluation report.

Inputs:
- Model performance: GMFE = 1.42, 91% within 2-fold
- External validation: Successful (GMFE = 1.58 on food effect study)
- Limitations: Only one pediatric study, no hepatic impairment data
- Application: Model will be used for dose selection in Phase 2

Structure:
1. Strengths (2-3 paragraphs)
2. Limitations (2-3 paragraphs)
3. Recommended applications (bulleted list with ✓/⚠/✗)
4. Future work (1 paragraph)

Tone: Professional, suitable for regulatory submission.
Length: ~500-750 words.
```

---

## References

1. Open Systems Pharmacology Documentation. https://docs.open-systems-pharmacology.org/
2. OSPSuite-R Documentation. https://www.open-systems-pharmacology.org/OSPSuite-R/
3. FDA Guidance on Physiologically Based Pharmacokinetic Analyses. 2018.
4. EMA Guideline on the Qualification and Reporting of Physiologically Based Pharmacokinetic Models. 2018.
5. Advancing Precision Medicine: Agentic AI in GNN-Enhanced PBPK Modeling. https://prikalra.github.io/precision-med-narrative-framework/

---

**Document Version**: 1.0
**Date**: 2024-03-20
**Author**: AI-Assisted Documentation System
**Maintained by**: Open Systems Pharmacology Community
